Layne Temoyan

Layne Temoyan has a diverse work experience spanning over several industries. They are currently an Associate Director, Key Accounts at TG Therapeutics, Inc. since November 2022. Prior to this, Layne worked as a NeuroPsych Account Specialist at Neurocrine Biosciences from September 2021 to November 2022. Before that, they were a Sr. Territory Business Manager (Alzheimer's Division) at Biogen from August 2020 to September 2021, where they played a key role in the launch of Aduhelm.

Layne's experience in the pharmaceutical industry includes roles at Novartis, where they worked as a Strategic Account Manager-Neuroscience Franchise from May 2017 to January 2020 and as a Multiple Sclerosis Sales Specialist from October 2013 to May 2017. They also worked as a Neuropsychiatry Specialty Sales Representative at inVentiv Health from October 2012 to October 2013.

Layne's earlier career includes positions at Thermo Fisher Scientific as a Clinical Sales Consultant, ImmunoDiagnostics from January 2012 to October 2012, at Merck as a Neuropsychiatry Specialty Sales from August 2009 to January 2012, at Schering-Plough Research Institute as a Professional Sales Representative from January 1999 to August 2009, at Innovex Inc. as a Professional Sales Representative from March 1998 to January 1999, and at Sherwin-Williams as a Senior Sales Representative from October 1994 to March 1998.

Layne Temoyan obtained a B.A. degree in Art History, Studio Arts, and Spanish from Arcadia University, where they studied from 1989 to 1993. Prior to attending Arcadia University, Layne completed their high school education at Upper Dublin High School from 1985 to 1989. In addition to their formal education, Layne has also obtained several certifications in various areas such as "Leading without Formal Authority," "Confronting Bias: Thriving Across Our Differences," "Transitioning to Management for Salespeople," and "Coaching Employees through Difficult Situations" from LinkedIn. These certifications were obtained in 2021.